SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-20-136357
Filing Date
2020-12-16
Accepted
2020-12-16 16:47:24
Documents
12
Period of Report
2020-10-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A tm2038649d1_8ka.htm   iXBRL 8-K/A 27106
  Complete submission text file 0001104659-20-136357.txt   198459

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nvax-20201031.xsd EX-101.SCH 3183
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvax-20201031_lab.xml EX-101.LAB 34591
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvax-20201031_pre.xml EX-101.PRE 22708
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2038649d1_8ka_htm.xml XML 3485
Mailing Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-26770 | Film No.: 201392979
SIC: 2836 Biological Products, (No Diagnostic Substances)